Arq Bras Endocrinol Metab 2006;50(2):360-367

Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome

José B.C. , Mario J.A.

DOI: 10.1590/S0004-27302006000200022

In the past years, in Brazil and in developed countries, obesity has become a major public health problem. It was identified that besides DM2 and metabolic syndrome other clinical entities were associated with insulin resistance. In this review we describe some of these alterations emphasizing nonalcoholic fatty liver disease, but also including polycistic ovary disease, hyperuricemia, chronic renal failure, heart failure, cognitive decline and cancer.

Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome

Comments (0)